Sunday, November 13, 2016
- 9:00AM-11:00AM
-
Abstract Number: 337
Denosumab Treatment for 10 Years in Postmenopausal Women with Osteoporosis Was Associated with Substantially Lower Fracture Incidence Relative to Their Baseline FRAX-Predicted Probability
Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis - Poster- 9:00AM-11:00AM
-
Abstract Number: 550
Despite Early Improvement and Limited Self-Reported Disability, Patients with Rheumatoid Arthritis Still Have Impaired Grip Strength 5 Years after Diagnosis
Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis- 9:00AM-11:00AM
-
Abstract Number: 58
Detecting Novel Candidate Risk Genes in Rheumatoid Arthritis with Gene-Based Association Testing
Genetics, Genomics and Proteomics - Poster I- 9:00AM-11:00AM
-
Abstract Number: 156
Detection of Finger Joint Osteophytes and Bone Erosions By Ultrasound; A Comparison to Computed Tomography and Histology
Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies- 9:00AM-11:00AM
-
Abstract Number: 422
Developing a Staff-Driven Electronic Smoking Cessation Referral Program in Rheumatology Clinics
Quality Measures and Quality of Care - Poster I- 9:00AM-11:00AM
-
Abstract Number: 686
Development and Evaluation of the Combined Ankylosing Spondylitis Spine Score (CASSS) for the Assessment of Spinal Radiographic Outcome
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment- 9:00AM-11:00AM
-
Abstract Number: 794
Development and Initial Validation of a Novel Lupus Disease Activity Index to Account for Glucocorticoids: Sledai-2K Glucocorticoids Index (SGI)
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster I: Clinical Trial Design and Current Therapies- 9:00AM-11:00AM
-
Abstract Number: 408
Development and Initial Validation of the Parent and Child Versions of the Juvenile Arthritis Disease Activity Score
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster I: Juvenile Idiopathic Arthritis, Uveitis- 9:00AM-11:00AM
-
Abstract Number: 680
Development and Preliminary Validation of the Computed Tomography Sacroiliac Structural Score for Assessment of Structural Lesions in Axial Spondyloarthritis
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment- 9:00AM-11:00AM
-
Abstract Number: 709
Development of a Novel Medication Adherence Prediction Model for Patients with Ankylosing Spondylitis Based on Results from a Global Clinical Study
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment- 9:00AM-11:00AM
-
Abstract Number: 837
Development of a Skin-Specific Scleroderma Patient Reported Outcome Instrument
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster I- 9:00AM-11:00AM
-
Abstract Number: 516
Development of RA Patient Preference Phenotypes
Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis- 9:00AM-11:00AM
-
Abstract Number: 708
Development of Spondyloarthritis-Features in Patients with Chronic Back Pain over a One-Year Course: Data from the Spondyloarthritis Caught Early (SPACE)-Cohort
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment- 9:00AM-11:00AM
-
Abstract Number: 20
Diabetes and Other Comorbidities in Rheumatoid Arthritis Patients Starting a Biologic DMARD: A Multi-Database Cohort Study
Epidemiology and Public Health - Poster I- 9:00AM-11:00AM
-
Abstract Number: 694
Diagnostic Delay Leads to Worse Response to Treatment